Advertisement
News
Advertisement

Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast

Tue, 08/03/2010 - 6:34am
Bio-Medicine.Org

SAN DIEGO, Aug. 3 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 30th Annual Canaccord Genuity Growth Conference on Tuesday, August 10.

The presentation by Scott Huennekens, president and chief executive officer, will begin at 9 a.m., Eastern Daylight Time (6 a.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.wsw.com/webcast/canaccord2/volc/ and via the company's website at www.volcanocorp.com.

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes consoles that can be integ

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading